Table 1.
Patient characteristics
| Year 1 | Year 2 | ||||
| Number of episodes (n) | 26 949 | 26 960 | |||
| Study site (n and %) | 1 | 1971 | 7 | 2039 | 8 |
| 2 | 5977 | 22 | 6108 | 23 | |
| 3 | 2172 | 8 | 2157 | 8 | |
| 4 | 3432 | 13 | 3447 | 13 | |
| 5 | 5087 | 19 | 4874 | 18 | |
| 6 | 2710 | 10 | 2831 | 10 | |
| 7 | 3125 | 12 | 3073 | 11 | |
| 8 | 2475 | 9 | 2431 | 9 | |
| Day-clinic (n and %) | 3444 | 13 | 3394 | 13 | |
| Female (n and %) | 12 304 | 46 | 12 343 | 46 | |
| Age at admission (years, mean and SD) | 47 | 18 | 47 | 18 | |
| Length of stay (days, median and IQR) | 17 | 8–33 | 17 | 8–33 | |
| Diagnostic group (n and %) | F0/G3 | 2419 | 9 | 2330 | 9 |
| F1 | 8980 | 33 | 8791 | 33 | |
| F2 | 4048 | 15 | 4086 | 15 | |
| F3 | 8147 | 30 | 8259 | 31 | |
| F4 | 1722 | 6 | 1650 | 6 | |
| F6 | 1252 | 5 | 1347 | 5 | |
| F7 | 185 | 1 | 265 | 1 | |
| Others | 196 | 1 | 228 | 1 | |
| NA | 0 | 0 | 4 | 0 |
IQR 25th–75th percentile.
Year 1: 1 October 2017 to 30 September 2018.
Year 2: 1 January 2019 to 31 December 2019.
F0, organic, including symptomatic, mental disorders; F1, mental and behavioural disorders due to psychoactive substance use; F2, schizophrenia, schizotypal and delusional disorders; F3, mood (affective) disorders; F4, neurotic, stress-related and somatoform disorders; F6, disorders of adult personality and behavior; F7, mental retardation; G3, other degenerative diseases of the nervous system.